Literature DB >> 9395230

Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen.

S R Goldstein1, G Y Yang, S K Curtis, K R Reuhl, B C Liu, S S Mirvish, H L Newmark, C S Yang.   

Abstract

In order to establish an animal model for studying the cause and prevention of esophageal adenocarcinoma (EAC) and its frequent precursor, Barrett's esophagus (BE), factors affecting the pathogenic processes were investigated in an esophagoduodenal anastomosis model with rats. Experiments by us and others have shown that surgical treatment produced reflux esophagitis with cell hyperproliferation, but not EAC. Additional treatment with a carcinogen has been shown to be necessary for the development of EAC, squamous cell carcinomas (SCC) or EAC/SCC mixtures. We found that the surgically treated animals developed anemia due possibly to reduced iron absorption. When the operated animals were supplemented with iron, EAC occurred at a high rate (73%) after 30 weeks, and treatment with N'-nitrosonornicotine did not enhance the rate of tumorigenesis. Treatment with carcinogen, however, induced SCC in the group of rats killed after 22 weeks. The results suggest that iron overload, which is known to cause oxidative damage, is an enhancing factor for adenocarcinogenesis. The pathogenesis of EAC in the iron-supplemented, non-carcinogen treated group resembles human esophageal adenocarcinogenesis in many features. All the BE was the specialized type with goblet cells (containing sialomucin or sulfomucin) and columnar cells (containing acid or neutral mucin) as well as an incompletely developed brush border. Almost all of the BE was located at the bottom of the esophagus and was continuous with the duodenal mucosa; dysplasia became more frequent at later time points. All of the cancers were well-differentiated mucinous EAC, and most of the EAC had an adjacent area of BE with dysplasia. The results are consistent with the proposed human sequence for pathogenic events of BE progression to 'BE with dysplasia' and then to EAC. Esophagoduodenal anastomosis and iron treatment in rats produces a high rate of BE and EAC which are morphologically similar to human BE and EAC; this may be a useful animal model to study the development and prevention of EAC in humans.

Entities:  

Mesh:

Year:  1997        PMID: 9395230     DOI: 10.1093/carcin/18.11.2265

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  50 in total

1.  The pathogenesis of Barrett's esophagus: a process in continuum or discontinuum.

Authors:  R C Fitzgerald; M J Farthing
Journal:  Curr Gastroenterol Rep       Date:  2000-12

2.  Reconstructive procedure after distal gastrectomy for gastric cancer that best prevents duodenogastroesophageal reflux.

Authors:  Kenichiro Fukuhara; Harushi Osugi; Nobuyasu Takada; Masashi Takemura; Masayuki Higashino; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-10-10       Impact factor: 3.352

3.  Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats.

Authors:  Koji Nishijima; Koichi Miwa; Tomoharu Miyashita; Shinichi Kinami; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Takanori Hattori
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

4.  What is the best reconstruction method after distal gastrectomy for gastric cancer?

Authors:  Moon-Soo Lee; Sang-Hoon Ahn; Ju-Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang; Nayoung Kim; Won Woo Lee
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

Review 5.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

6.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Authors:  H Kazumori; S Ishihara; M A K Rumi; Y Kadowaki; Y Kinoshita
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

7.  Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux.

Authors:  T J Jang; S K Min; J D Bae; K H Jung; J I Lee; J R Kim; W S Ahn
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model.

Authors:  C Poplawski; D Sosnowski; A Szaflarska-Popławska; J Sarosiek; R McCallum; Z Bartuzi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling.

Authors:  Daniel S Oh; Steven R DeMeester; Christy M Dunst; Ryutaro Mori; Bethany J Lehman; Hidekazu Kuramochi; Kathleen Danenberg; Peter Danenberg; Jeffrey A Hagen; Parakrama Chandrasoma; Tom R DeMeester
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.

Authors:  D F Peng; M Razvi; H Chen; K Washington; A Roessner; R Schneider-Stock; W El-Rifai
Journal:  Gut       Date:  2008-07-29       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.